Pr Christophe Massard

Specialty

Oncologist, bladder expert, prostate expert

Title

Head of the Early Trials Department (DITEP)

Hospital

Gustave Roussy (Villejuif)

Latest articles

• New therapies for brain metastases: an update. (Nov 1, 2025)
• [TRANSFORM-O: A new training program in translational research offered by the French Society of Cancer (SFC) and the French National College of Oncology Teachers (CNEC)]. (Oct 1, 2025)
• The future of androgen receptor targeting in prostate cancer: third-generation inhibitors and beyond. (Sep 29, 2025)
• Notch pathway inhibition with crenigacestat (LY3039478) in a phase I first-in-human clinical trial for patients with relapsed or refractory non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia. (Jul 31, 2025)
• Autocrine interferon poisoning mediates ADAR1-dependent synthetic lethality in BRCA1/2-mutant cancers. (Jul 29, 2025)